Download Mobile App

Partner Sites

LabMedica

AI Tool Predicts Immunotherapy Response Using Tumor Senescence Signals

Daily Blood Biomarker Testing May Help Guide Earlier Antibiotic Stopping in Sepsis

Blood Proteins Reveal Signals Linked to Prostate Cancer Risk Years Before Diagnosis

Collaboration to Expand Cervical Cancer Screening Access With At-Home HPV Collection

Single-Cell Profiling Reveals Chemotherapy Resistance Signals in Ovarian Cancer

Featured Links

Medical Equipment Marketplace
Visit our all new website Trademed.com where buyers and sellers can find the best medical device and equipment.

Oridis Licenses Tissue Microarray Technology

By Labmedica staff writers
Posted on 05 Dec 2006

Oridis Biomed (Graz, Austria), a biopharmaceutical company, announced that it has entered into a license agreement with the National Institutes of Health (NIH, Bethesda, MD, USA) for the worldwide commercial use of NIH's proprietary tissue microarray (TMA).

TMAs are a tool within Oridis Biomed's Tissomics platform, which permits the rapid and simultaneous study of several hundred tissue samples, using standardized high-throughput analysis by in-house pathologists.

"We are pleased to have been granted by the NIH a license for this TMA technology”, said Georg Casari, Ph.D., head of Oridis Biomed's Tissomics business. More...

"This license agreement further strengthens our Tissomics business for the life-science industry worldwide, where we offer our clients the ability to validate their research, such as biomarker and target verification programs.”

Oridis Biomed commercializes its proprietary Tissomics platform in collaboration with industrial partners, as well as its own research and development programs. The company is developing diagnostics, biomarkers (targeted treatment solutions), and therapeutics for liver diseases. Therapeutic programs include primary liver cancer (hepatocellular carcinoma, HCC) and metabolic liver diseases, such as alcoholic steatohepatitis (ASH) and non- alcoholic steatohepatitis (NASH), where incidence rates are rapidly increasing, while treatment options are limited, expensive, and often ineffective.

Related Links:
Oridis Biomed
National Institutes of Health

Visit expo >

Gold Member

Neonatal Heel Incision Device

Tenderfoot

Hand-held Hemoglobin Analyzer
DiaSpect Tm

Hypodermic Syringe

SurTract™ Safety Syringe

Surgical System

Stealth AXiS

Read the full article by registering today, it's FREE!

Free digital version edition of HospiMedica International sent by email on regular basis
Free print version of HospiMedica International magazine (available only outside USA and Canada).
Free and unlimited access to back issues of HospiMedica International in digital format
Free HospiMedica International Newsletter sent every week containing the latest news
Free breaking news sent via email
Free access to Events Calendar
Free access to LinkXpress new product services
REGISTRATION IS FREE AND EASY!

Sign in: Registered website members

Sign in: Registered magazine subscribers

Latest Technology News

Channels

Artificial Intelligence

view channel

$Image: Mass General Brigham researchers developed two AI tools from one foundation model (called FAHR-Face) that can estimate biological age and predict cancer survival outcomes from a single face photo. The image on the left depicts the features most important to FAHR-FaceSurvival\'s predictions of cancer survival outcomes, while the image on the right shows the features most important to FAHR-FaceAge\'s estimates of biological age. Areas shown in yellow had the greatest influence on each model\'s predictions. (Photo courtesy of Mass General Brigham/Lancet Digital Health)$

$Image: Purdue University physicist David Nolte is developing a biodynamic imaging system that could improve the care of cancer patients undergoing chemotherapy. Nolte\'s system can rapidly evaluate the outcome of different chemotherapy drugs on patient biopsies (obtained during diagnosis), which could ensure patients get the chemotherapy treatment that would be most effective on their specific tumor. Right now, the system is being used at the Indiana University School of Medicine to evaluate the impact of experimental chemotherapy drugs on tumor cells derived from more than 30 osteosarcoma patients. It has also been used in clinical and preclinical trials. (IMage Credit: Purdue University/Kelsey Lefever)$

Optical Imaging System Helps Predict Chemotherapy Response in Cancer

Selecting chemotherapy can be difficult because tumors from different patients may respond differently to the same drug. Testing treatment effects directly on living tumor tissue could help clinicians... Read more

Critical Care

view channel

Smart Medical Adhesive Patch Uses Heat to Enable Gentle Removal

Medical adhesive-related skin injury (MARSI) is a persistent concern for neonates, older adults, critically ill patients, and others requiring repeated monitoring. Strong adhesives keep sensors securely... Read more

Smart Pulse Oximetry Supports Earlier Recognition of Arrhythmias and Respiratory Risk

On general care floors, respiratory compromise and arrhythmias can develop between routine checks. Atrial fibrillation often goes undiagnosed in older adults, while opioid-induced respiratory depression... Read more

Proposed Risk Score Prioritizes Sickest Patients for Heart Transplant

Donor hearts remain extremely scarce in the U.S. transplant system, with one in five candidates dying or being removed from the waiting list before receiving an organ. Current allocation rules may also... Read more

Wearable Robotic Gait Training Linked to Improved Walking Distance in ALS

Amyotrophic lateral sclerosis (ALS) is a progressive neuromuscular disease that damages nerve cells controlling voluntary muscles. As the disease advances, patients can lose the ability to walk, speak,... Read more

Surgical Techniques

view channel

Dual-Imaging Catheter Completes Initial Human Evaluation of Coronary Plaque

Atherosclerosis involves plaque buildup in arterial walls that can narrow blood vessels and increase the risk of heart attack, stroke, and other serious cardiovascular conditions. In coronary arteries,... Read more

Combined Wound Healing Approach Pairs Synthetic Scaffold With Negative Pressure Therapy

Managing complex wounds requires both structural support for tissue repair and a controlled environment that protects the healing process. Frequent dressing changes can disrupt the wound bed and add complexity... Read more

Shape-Changing Hydrogels Show Promise for Tissue Engineering and Wound Healing

Human tissues often have complex three-dimensional shapes that are closely tied to their function, but recreating these curvatures remains challenging in tissue engineering and wound repair.... Read more

$Image: The new technology uses augmented reality to overlay a 3D visualization of the tumor and other anatomical structures on the surgeon\'s camera view. Here, Niclas Kvarnström, transplant surgeon and head of the Transplant Centre, and Fatuma Shieriye, specialist physician, perform the first operation using the new technology. (Image Credit: Jenny Cedås)$